E-LIB Suche - Ergebnisse für: Tremblay, Douglas

1

Emerging Treatment Options for Myelofibrosis: Focus on Anem..:

Sastow, Dahniel ; Tremblay, Douglas
info:eu-repo/semantics/altIdentifier/doi/10.2147/TCRM.S386802. , 2023

Link: https://www.dovepress.co..

2

Cytoreduction for ET and PV: who, what, when, and how?:

Tremblay, Douglas
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727012/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Energy expenditure in myelofibrosis patients treated with a..:

Tremblay, Douglas ; Dougherty, Mikaela ; Mascarenhas, John.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339379/. , 2023

Link: http://www.ncbi.nlm.nih...

4

PB2231: AN OVERLOOKED MIMIC? AUTOIMMUNE MYELOFIBROSIS - A S..:

Riazat-Kesh, Yosef Joseph Rene Amel ; Maraveyas, Alexander ; Martin, Lily.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428719/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Emerging Treatment Options for Myelofibrosis: Focus on Anem..:

Sastow, Dahniel ; Tremblay, Douglas
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315142/. , 2023

Link: http://www.ncbi.nlm.nih...

6

CNL and aCML are prognostically distinct: a large National ..:

Tremblay, Douglas ; Sastow, Dahniel ; Mascarenhas, John
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432596/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Efficacy and Safety of Pacritinib vs Placebo for Patients W..:

Cafardi, John ; Miller, Carole ; Terebelo, Howard...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855296/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Male-specific late effects in adult hematopoietic cell tran..:

Phelan, Rachel ; Im, Annie ; Hunter, Rebecca L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316716/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Efficacy and Safety of Pacritinib vs Placebo for Patients W..:

Cafardi, John ; Miller, Carole ; Terebelo, Howard...
https://jdc.jefferson.edu/einsteinfp/1. , 2022

Link: https://jdc.jefferson.ed..

10

Male-specific late effects in adult hematopoietic cell tran..:

Phelan, Rachel ; Im, Annie ; Hunter, Rebecca L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050968/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Combined Drug Targeting of p53-dependent and -independent P..:

Lu, Min ; Xia, Lijuan ; Elmansy, Nada...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885407/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Male-specific late effects in adult hematopoietic cell tran..:

Phelan, Rachel ; Im, Annie ; Hunter, Rebecca L...
https://boris.unibe.ch/161271/. , 2022

Link: https://boris.unibe.ch/1..

13

Contemporary Risk Stratification and Treatment of Chronic M..:

Tremblay, Douglas ; Rippel, Noa ; Feld, Jonathan..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100553/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Clinical Utility of Fedratinib in Myelofibrosis:

Waksal, Julian A ; Tremblay, Douglas ; Mascarenhas, John
info:eu-repo/semantics/altIdentifier/doi/10.2147/OTT.S267001. , 2021

Link: https://www.dovepress.co..

15

Cardiovascular Disease and Severe Hypoxemia Are Associated ..:

Wang, Jing Gennie ; Liu, Bian ; Percha, Bethany...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909114/. , 2021

Link: http://www.ncbi.nlm.nih...